A truly integrated  healthcare advertising agency for the biggest & most ambitious brands.

Yes, absolutely. Synapse has proven expertise at both ends of the brand lifecycle. For breakthrough molecules, we excel at translating complex trial data and mechanisms of action into clear, compliant, and persuasive launch strategies. Our work on launches like Alembic's Tofastar (rheumatoid arthritis treatment) and Mankind's Dynaglipt (advanced diabetes molecule) demonstrates our ability to establish market differentiation from day one.

For mature or legacy brands, we specialize in repositioning, share recovery, and category revitalization. Our ongoing partnerships with brands like Cipla's Foracort (No. 1 respiratory brand) and Glenmark's Ascoril (No. 1 cough syrup in India) show how clinical superiority and strategic storytelling can sustain and grow established market leaders.

Whether you're launching a breakthrough or reviving a heritage brand, we bring data-driven strategy, clinical credibility, and creative excellence to overcome market challenges and drive adoption.

Synapse operates as a full-service healthcare marketing agency. We offer end-to-end capabilities: strategic positioning and commercial roadmaps, creative concept development (design, copy, video), digital marketing and media strategy, field force enablement and in-clinic tools, patient awareness campaigns, and compliance-first regulatory guidance.

That said, we're flexible. Clients can engage us for strategy consultation alone, creative execution only, or full integrated campaigns. We've managed national product launches (Abbott, Cipla, Krsnaa Diagnostics), supported OTC brand scaling (Micro Labs, Himalaya), built healthtech awareness programs, and designed diagnostic marketing campaigns. Whether your need is a single campaign asset, an integrated multi-channel launch, or ongoing brand stewardship, we customize our engagement model to fit your goals and structure.

We work across the entire healthcare spectrum. While pharma is our heritage, Synapse today serves pharmaceutical companies, hospitals, diagnostic chains, dermo-cosmetic brands, medical device manufacturers, OTC/OTX brands, health consumer durables, and healthtech startups. Our clientele spans Abbott, Cipla, Himalaya, JB Pharma, Lupin, Emcure, Glenmark, Alkem, Avantor, Meril, Pfizer, Dr. Reddy's, USV, Xelix, Genoroot, and many more across all therapeutic areas.

We're also Pan-India and internationally focused, working with brands in tier-1 metros and tier-2 cities, and increasingly supporting global healthcare organizations entering or scaling in India. Whether your business is clinical research, diagnostics, digital health, or pharmaceutical, we bring the same scientific rigor, creative excellence, and omnichannel execution to your healthcare communication challenge.

This is core to who we are. We are a compliance-first agency - every claim we make is grounded in medical evidence, aligned with regulatory guidelines (DCGI, IPC, AMA standards), and reviewed against applicable frameworks. However, compliance is never an excuse for mediocrity. Our founders bring both clinical and creative credibility: Rahul Pandit and JB Bhagat are JJ School of Art alumni, combining design and artistic sensibility with Aleem Merchant's strategic and commercial expertise.

The result? We innovate within constraints. Our campaigns for Cipla's Foracort won over 20 awards; our work for Pfizer on PID awareness and JB Pharma on respiratory health won India's first global award in healthcare marketing. We translate dense trial data into human stories, build interactive digital experiences that comply with regulations, and create field force tools that are both clinically rigorous and emotionally resonant. Regulatory excellence and creative brilliance aren't mutually exclusive - they're mutually reinforcing.

Our track record speaks for itself. We've won over 20 awards for Cipla's respiratory portfolio alone. JB Pharma's social media content won the ET Best Social Media Content Campaign 2024. Our work with Abbott earned India's First Global Award in Healthcare Marketing. We were the exclusive marketing partner for Krsnaa Diagnostics, India's largest PPP diagnostic chain, and managed the branding for CPHI India (2022, 2023, 2024) - the world's largest pharmaceutical exhibition.

Beyond awards, we measure success by client business outcomes: prescription adoption for newly launched molecules, market share recovery for mature brands, patient awareness and adherence improvements, and digital engagement metrics. Our portfolio spans 40+ healthcare brands across pharmaceuticals, diagnostics, hospitals, devices, and healthtech. For specific ROI case studies tailored to your therapeutic area or business model, we invite you to explore our case studies or schedule a consultation. Every engagement is benchmarked for measurable impact.

Speed is one of our competitive advantages. Because we've built pre-validated strategic frameworks, regulatory compliance templates, creative asset libraries, and a deep bench of specialists, we can move faster than most agencies without sacrificing rigor.

Typical timelines: Strategic positioning and roadmaps (2–4 weeks), concept-to-launch campaigns (4–6 weeks), digital and media activation (concurrent with creative), ongoing brand stewardship (ongoing). However, speed depends on scope complexity - a single-asset campaign moves faster than a national launch across multiple channels. We also leverage agile methodology, breaking larger projects into sprints so you see work early and iterate in real time.

If you're under launch pressure or entering a new market window, bring us in early. Our ability to compress timelines without cutting corners is a key differentiator for brands in growth mode.